Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$645M |
| 2 |
T-Mobile US
TMUS
|
+$640M |
| 3 |
AT&T
T
|
+$517M |
| 4 |
Humana
HUM
|
+$481M |
| 5 |
Boston Scientific
BSX
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$755M |
| 3 |
Meta Platforms (Facebook)
META
|
+$707M |
| 4 |
Caterpillar
CAT
|
+$472M |
| 5 |
Advanced Micro Devices
AMD
|
+$449M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.33% |
| 2 | Technology | 3.2% |
| 3 | Financials | 2.22% |
| 4 | Industrials | 2.17% |
| 5 | Consumer Discretionary | 2.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
13476
PUT
Plexus
PLXS
$7.13B
| $9.76K | ﹤0.01% |
+100
| New | +$10K |
|
13477
Pasithea Therapeutics
KTTA
$16.1M
| $9.75K | ﹤0.01% |
+1,253
| New | +$14.2K |
|
|
NEUE
13478
CALL
DELISTED
NeueHealth
NEUE
| $9.74K | ﹤0.01% |
553
-155
| -22% | -$7.99K |
|
|
THM
13479
International Tower Hill Mines
THM
$712M
| $9.73K | ﹤0.01% |
16,219
-89,806
| -85% | -$50.7K |
|
13480
CALL
RELX
RELX
$60B
| $9.73K | ﹤0.01% |
+300
| New | +$9K |
|
13481
PUT
Tucows
TCX
$126M
| $9.72K | ﹤0.01% |
+500
| New | +$14.4K |
|
|
OLOX
13482
Olenox Industries
OLOX
$3.7M
| $9.71K | ﹤0.01% |
+2
| New | +$14.9K |
|
13483
CALL
StepStone Group
STEP
$4.15B
| $9.71K | ﹤0.01% |
400
-300
| -43% | -$8.2K |
|
|
SGTX
13484
CALL
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
| $9.67K | ﹤0.01% |
800
-1,262
| -61% | -$13.1K |
|
13485
PUT
Information Services Group
III
$250M
| $9.67K | ﹤0.01% |
1,900
+600
| +46% | +$3.08K |
|
13486
CALL
Blend Labs
BLND
$352M
| $9.66K | ﹤0.01% |
9,700
+3,100
| +47% | +$4.75K |
|
13487
CALL
Neurogene
NGNE
$723M
| $9.66K | ﹤0.01% |
+690
| New | +$8.09K |
|
13488
PUT
Viemed Healthcare
VMD
$350M
| $9.66K | ﹤0.01% |
+1,000
| New | +$8.72K |
|
|
DMRA
13489
Damora Therapeutics
DMRA
$1.92B
| $9.65K | ﹤0.01% |
+194
| New | +$10.2K |
|
|
CDTX
13490
CALL
DELISTED
Cidara Therapeutics
CDTX
| $9.65K | ﹤0.01% |
380
-1,795
| -83% | -$50.9K |
|
13491
Liquidia Corp
LQDA
$6.66B
| $9.61K | ﹤0.01% |
+1,390
| New | +$9.49K |
|
13492
PUT
Shenandoah Telecom
SHEN
$735M
| $9.51K | ﹤0.01% |
500
-400
| -44% | -$7.47K |
|
13493
Delek Logistics
DKL
$2.87B
| $9.48K | ﹤0.01% |
200
+144
| +257% | +$7.04K |
|
13494
CALL
Lipocine
LPCN
$17.4M
| $9.48K | ﹤0.01% |
1,753
-3,606
| -67% | -$27.9K |
|
13495
Marchex
MCHX
$82M
| $9.46K | ﹤0.01% |
5,196
-1,385
| -21% | -$2.67K |
|
13496
PUT
GameSquare
GAME
$43M
| $9.45K | ﹤0.01% |
1,750
+1,725
| +6,900% | +$9.87K |
|
|
TEF
13497
PUT
DELISTED
Telefonica
TEF
| $9.42K | ﹤0.01% |
2,200
-8,600
| -80% | -$34.1K |
|
|
OSG
13498
CALL
DELISTED
Overseas Shipholding Group Inc.
OSG
| $9.36K | ﹤0.01% |
2,400
-21,800
| -90% | -$78.6K |
|
|
JFIN
13499
CALL
Jiayin Group
JFIN
$119M
| $9.32K | ﹤0.01% |
2,500
| – | – |
|
13500
CALL
Xtrackers MSCI EAFE High Dividend Yield Equity ETF
HDEF
$2.34B
| $9.32K | ﹤0.01% |
+400
| New | +$9.11K |
|
Similar funds
Ken Griffin's Q1 2023 Portfolio in Review
As of Q1 2023, Ken Griffin held 16,292 positions worth $455B, up 6.2% from $428B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Ken Griffin withdrew a net $26.7B in Q1 2023, closing 1,652 positions and reducing 6,687 holdings. Its most notable exit was Restaurant Brands International, an estimated $93.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.3% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
Against the trend, Ken Griffin opened a new position in Keurig Dr Pepper worth $238M.
- Ken Griffin's largest Q1 2023 buy was Keurig Dr Pepper: 6,751,572 shares worth $238M.
- Ken Griffin added most to Invesco QQQ Trust in Q1 2023, an estimated $645M increase.
- Ken Griffin's biggest Q1 2023 reduction was Tesla, cutting an estimated $1.24B.
- Ken Griffin fully exited Restaurant Brands International in Q1 2023, selling an estimated $93.3M.
- Ken Griffin's ten largest holdings make up 33% of its $455B portfolio in Q1 2023.
- Ken Griffin opened 1,466 new positions and closed 1,652 in Q1 2023.
- Ken Griffin's portfolio value rose 6.2% quarter-over-quarter to $455B.
Based on Citadel Advisors's 13F filing for Q1 2023, filed 15 May 2023.